Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

287 trials

NCT07184996
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 3 · Argentina, Austria, Australia, Bulgaria, Canada, Switzerland, China, Czechia, Germany, France, Georgia, Hungary, Italy, Japan, Lithuania, Moldova, Netherlands, Poland, Puerto Rico, Serbia, Slovakia, Taiwan, Ukraine, United States, South Africa · 240 sites
Registry update: 23 Oct 2026
NCT07385131
Recruiting
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
Not applicable · China · 1 site
Registry update: 3 Feb 2026
NCT07243639
Recruiting
Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis
Not applicable · Japan · 1 site
Registry update: 21 Jul 2026
NCT06420492
Recruiting
Study of Novel Therapeutics for Acute Remedy of Colitis
Phase 2 · United States · 1 site
Registry update: 20 Oct 2025
NCT06865417
Recruiting
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Belgium, Germany, Spain, France, United Kingdom, Greece, Croatia, Ireland, Italy, Norway, Poland, Portugal, Romania · 46 sites
Registry update: 20 Oct 2026
NCT06979336
Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Phase 2 · Australia, Brazil, Canada, China, Czechia, Germany, France, United Kingdom, India, Italy, Japan, South Korea, Mexico, Poland, United States · 118 sites
Registry update: 27 Oct 2026
NCT06742385
Recruiting
Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases
Not applicable · France · 1 site
Registry update: 24 Sept 2025
NCT07168499
Recruiting
Diet and Stress Management Combined With Advanced Therapy for Crohn's and Ulcerative Colitis
Not applicable · United States · 1 site
Registry update: 6 Nov 2025
NCT07191106
Recruiting
Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)
Not applicable · France · 2 sites
Registry update: 24 Sept 2025
2023-503509-12-00
Recruiting
Model-informed precision dosing during infliximab rescue therapy for patients with steroid-refractory acute severe ulcerative colitis: an exploratory study (the IGNITE study)
Phase 4 · Belgium · 1 site
Registry update: 11 Aug 2026
NCT07261826
Recruiting
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
Not applicable · China · 1 site
Registry update: 3 Dec 2025
2024-520201-39-00
Recruiting
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Phase 2 · Austria, Belgium, Czechia, Croatia, Hungary, Lithuania, Poland · 18 sites
Registry update: 31 Jul 2026
Conflicting statuses (not updated in the registry for 3 months)
NCT07102368
Recruiting
A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
Not applicable · Germany · 1 site
Registry update: 3 Nov 2026
NCT07080034
Recruiting
Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis
Phase 2 · Russia · 19 sites
Registry update: 19 Sept 2025
NCT07114159
Recruiting
Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis
Not applicable · China · 1 site
Registry update: 11 Aug 2025
NCT07111273
Recruiting
DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis
Not applicable · China · 1 site
Registry update: 28 Jul 2026
NCT07111572
Recruiting
Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis
Not applicable · China · 1 site
Registry update: 28 Jul 2026
NCT07071519
Recruiting
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Phase 3 · Belgium, Brazil, Canada, China, Germany, Spain, United Kingdom, Greece, Italy, Japan, South Korea, Poland, Serbia, Sweden, Taiwan, United States · 75 sites
Registry update: 27 Oct 2026
NCT06805890
Recruiting
Study of Tissue Repair in Inflammatory Bowel Disease Exploiting Organoid Technology
Not applicable · France · 1 site
Registry update: 21 Sept 2026
NCT07013578
Recruiting
TIDHI Mental Health in IBD Patients Study
Not applicable · Canada · 1 site
Registry update: 29 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.